Literature DB >> 7715767

Participation of opiate delta-receptors in immunomodulation.

M A Cheido1, G V Idova.   

Abstract

The activation of the opiate delta-receptors by the highly specific agonist DSLET evokes an immunoinhibitory effect in CBA mice which disappears with preliminary blockade of S2 serotonin receptors by cyproheptadine. The blockade of delta-receptors by the antagonist ICI 174,864 leads to stimulation of the immune response, which is tested on the basis of the number of rosette-forming cells. Neither stimulation nor suppression of immunogenesis are manifested in animals with a transsected hypophyseal stalk; this suggests the central action of the opioids. The increase in the immune response obtained with the administration of ICI 174,864 is associated with the dopaminergic system, since it is prevented by haloperidol. It was demonstrated that the thymus participates in the immune-stimulating influence of ICI 174,864.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7715767     DOI: 10.1007/bf02360170

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  15 in total

1.  Dopamine denervation of the nucleus accumbens induces a selective increase in the number of delta-opioid binding sites.

Authors:  E Esposito; L Cervo; P Petrillo; M Sbacchi; A Tavani; R Samanin
Journal:  Brain Res       Date:  1987-12-08       Impact factor: 3.252

Review 2.  Dopaminergic stimulation of the immune reaction: interaction of serotoninergic and dopaminergic systems in neuroimmunomodulation.

Authors:  L Devoino; E Alperina; G Idova
Journal:  Int J Neurosci       Date:  1988-06       Impact factor: 2.292

3.  D-Tyr--Ser-Gly--Phe--Leu--Thr, a highly preferential ligand for delta-opiate receptors.

Authors:  G Gacel; M C Fournie-Zaluski; B P Roques
Journal:  FEBS Lett       Date:  1980-09-08       Impact factor: 4.124

4.  ICI 174864: a highly selective antagonist for the opioid delta-receptor.

Authors:  R Cotton; M G Giles; L Miller; J S Shaw; D Timms
Journal:  Eur J Pharmacol       Date:  1984-01-27       Impact factor: 4.432

5.  Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain.

Authors:  A Mansour; H Khachaturian; M E Lewis; H Akil; S J Watson
Journal:  J Neurosci       Date:  1987-08       Impact factor: 6.167

6.  [Comparison of the neuro- and immunomodulator properties of low-molecular neuropeptides].

Authors:  E M Kukaĭn; R K Mutsenietse; V E Klusha
Journal:  Biull Eksp Biol Med       Date:  1982-08

7.  Enkephalins and immunity. I: In vivo suppression and potentiation of humoral immune response.

Authors:  B D Janković; D Marić
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

8.  Enkephalins and immunity. II: In vivo modulation of cell-mediated immunity.

Authors:  D Marić; B D Janković
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

9.  Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D-penicillamine, 5-D-penicillamine]enkephalin (125I-DPDPE).

Authors:  R P Dilts; P W Kalivas
Journal:  Synapse       Date:  1990       Impact factor: 2.562

10.  Serotonergic regulation of the brain and gut beta-endorphin and dynorphin content in the rat.

Authors:  N H Majeed; W Lasoń; B Przewłocka; R Przewłocki
Journal:  Pol J Pharmacol Pharm       Date:  1985 Nov-Dec
View more
  2 in total

Review 1.  Drugs of abuse, immune modulation, and AIDS.

Authors:  Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-28       Impact factor: 4.147

Review 2.  A "Drug-Dependent" Immune System Can Compromise Protection against Infection: The Relationships between Psychostimulants and HIV.

Authors:  María Amparo Assis; Pedro Gabriel Carranza; Emilio Ambrosio
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.